Do we need a replacement medication for influenza with good efficacy?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Applied Mathematics,General Mathematics
Link
http://link.springer.com/content/pdf/10.1186/s40199-014-0084-3.pdf
Reference17 articles.
1. Jeferson T, Jones MA, Doshi P, DelMar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, Howick J, Heneghan CJ: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.The Cochrane Collaboration, Wiley & Sons, Ltd 2014, (4):24. www.thecochranelibrary.com .,
2. Torjesen I: Cochrane review questions effectiveness of neuraminidase inhibitors.BJM 2014, 348. g 2675/dio: 10.1136/bmj.g2675.,
3. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TSA, Al Mamun A, Anovadiya AP, Azziz-Baumgartner E, Báez C, Bassetti M, Beovic B, Bertisch B, Bonmarin I, Booy R, Borja-Aburto VH, Burgmann H, Cao B, Carratala J, Denholm JT, Dominguez SR, Duarte PAD, Dubnov-Raz G, Echavarria M, Fanella S, Gao Z, Gerardin P, Giannella M, Gubbels S, Herberg J, Iglesias ALH: Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. 2014, , 2014 http://dx.doi.org/10.1016/S2213-2600(14)70041-4 ., [ www.thelancet.com/respiratory ]
4. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA: Isolation of a novel corona virus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012, 367: 1814-1820. 10.1056/NEJMoa1211721.
5. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RAM, Galiano M, Gorbalenya AE, Memish Z, Perlman S, Poon LLM, Snijder EJ, Stephens JM, Woo PCY, Zaki AM, Zambon M, Ziebuhr J: Middle East respiratory syndrome corona virus (MERS-CoV); announcement of the corona virus study group. J Virol. 2013, 87: 7790-7792. 10.1128/JVI.01244-13.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3